Topcon Healthcare Launches TERA Dry Eye Imager to Advance DED Diagnosis and Management

Topcon Healthcare has introduced the TERA Dry Eye Imager, a new multimodal platform aimed at improving the detection, grading, and management of dry eye disease (DED). The system combines robotic automation, high-resolution imaging, and patient-centered diagnostics, aligning with the TFOS DEWS III framework to enhance both clinical efficiency and patient engagement.

The TERA Dry Eye Imager is engineered to streamline pretesting and standardize dry eye evaluations in clinical practice. Key features of the platform include:

       • One-touch automated alignment, focus, and image capture, supported by eye tracking where applicable, which minimizes variability and reduces staff training time.

       • Guided focus functions for meibography and tear meniscus height that help ensure consistent, high-quality imaging.

       • A rotatable monitor that can be operated from either side of the patient chair, improving ergonomics, workflow, and space efficiency.

Topcon notes that these capabilities allow clinics to increase patient throughput without compromising on diagnostic accuracy.

Imaging Capabilities Designed to Support Diagnostic Consistency

TERA utilizes advanced optics and patented diffused white light technology to provide noninvasive, high-resolution visualization of the ocular surface and tear film lipid layer. The system also integrates:

       • Corneal topography

       • Pupillometry

       • A dedicated dry eye suite featuring validated grading scales such as Efron, JENVIS, and Meiboscale

Aligned with the TFOS DEWS III diagnostic framework, the TERA platform incorporates both subjective assessments, such as OSDI-6, and objective measures including noninvasive tear break-up time (NIBUT), ocular surface staining, and meibography.

Supporting Patient Interaction and Clinical Workflow Efficiency

According to Topcon, TERA transforms complex diagnostic findings into personalized, visual narratives that help patients better understand their condition and treatment options. These discussions can include therapies such as intense pulsed light (IPL) and radiofrequency (RF).

“Dry eye care is no longer just about diagnosis; it is about building a service that patients understand and value,” said Rupe Hansra, OD, Vice President of Professional Affairs at Topcon Healthcare, Inc.
“TERA helps practices stand out by combining advanced imaging with tools that improve patient education and treatment discussions, creating both better outcomes for patients and new opportunities for practice growth.”

Reference:

TFOS DEWS III: Diagnostic Methodology, American Journal of Ophthalmology, May 30, 2025. doi:10.1016/j.ajo.2025.05.033